Synaptogenix, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 22
Rang # Quantité totale PI 67 805
Note d'activité PI 2,3/5.0    26
Rang # Activité PI 30 741
Symbole boursier SNPX (nasdaq)
ISIN US87167T2015
Capitalisation 4.100M  (USD)

Brevets

Marques

15 0
0 0
7 0
0
 
Dernier brevet 2025 - Treatment of amyotrophic lateral...
Premier brevet 2019 - Halogenated esters of cyclopropa...

Derniers inventions, produits et services

2024 Invention Treatment of amyotrophic lateral sclerosis using pkc activators. A method for treating or preven...
Invention Methods of treating and preventing neurodegenerative diseases with hgf activating compounds. A m...
Invention Methods for repairing nerve damage using pkc activating therapeutic agents. A method for treating...
Invention Methods for repairing nerve damage using pkc activating therapeutic agents. A method for treatin...
2023 Invention Pkc-activating compounds for the treatment of neurodegenerative diseases. The present invention ...
Invention Method of enhancing recovery from long covid. A method for treating or preventing long COVID in a...
2022 Invention Pkc-activating compounds for the treatment of neurodegenerative diseases. The present invention r...
Invention Method of inducing synaptogenesis by administering angiotensin and analogues thereof. A method fo...
Invention Treatment of multiple sclerosis using pkc activators. A method for treating or preventing mild, ...
Invention Treatment of optic nerve inflammation using pkc activators. A method for treating or preventing ...
Invention Treatment of multiple sclerosis using pkc activators. A method for treating or preventing mild, m...
Invention Treatment of optic nerve inflammation using pkc activators. A method for treating or preventing o...
Invention Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurode...
2021 Invention Treatment of amyotrophic lateral sclerosis using pkc activators. A method for treating or prevent...
Invention Methods of treating and preventing neurodegenerative diseases with hgf activating compounds. A me...
Invention Method of inducing synaptogenesis by administering angiotensin and analogues thereof. A method f...
Invention Methods and compositions for treatment of alzheimer's disease and other neurodegenerative disorde...
2020 Invention Dosing regimens of pkc activators. Dosing regimens and methods are disclosed for upregulating pro...
Invention Methods for inducing synaptogenesis with synaptic growth factor activating compounds. A method fo...